SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-077088
Filing Date
2024-03-26
Accepted
2024-03-26 07:15:30
Documents
15
Period of Report
2024-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d796361d8k.htm   iXBRL 8-K 25311
2 EX-99.1 d796361dex991.htm EX-99.1 39804
6 GRAPHIC g796361g0322035409186.jpg GRAPHIC 3967
  Complete submission text file 0001193125-24-077088.txt   209219

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vigl-20240326.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20240326_lab.xml EX-101.LAB 19500
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20240326_pre.xml EX-101.PRE 12162
18 EXTRACTED XBRL INSTANCE DOCUMENT d796361d8k_htm.xml XML 3923
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 24780888
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)